RFQ.pdf

Solicitation No. 75N95025Q00200

Title: Miniature two-photon microscope system for mice with maintenance and installation services.

i. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a separate written solicitation will not be issued.

ii. This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items and is not expected to exceed the simplified acquisition threshold. A fixed-price type of purchase order is contemplated for this requirement.

iii. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-05, with effective date 08/07/25.

iv. The North American Industry Classification System (NAICS) code for this procurement is 334516 – Analytical Laboratory Instrument Manufacturing and the small business size standard is 1,000 employees. This requirement is full and open with no set-aside restrictions.

v. The purpose of this requirement is to provide NIDA with a miniature two-photon microscope system for mice to record activities of single neurons in unrestraint conscious mice.

The Government requires one (1) Imaging system that:

- Records calcium-indicator activities of single neurons and axonal and dendritic structures while mice are not restraint and engage in tasks.

- A light-weight and compact system is desired, approximately 2.5 g and approx. 20 x 10 x 30 mm in size.

The offeror should provide installation and maintenance services for the system. In addition, the system preferably should be compatible with the laser that NIDA currently has (2-photon laser - Spectra-Physics Mai Tai HP with s/n 5192).

vi. Delivery shall be made 90 days after the award date. Delivery shall be made to the following:

NIH, NIDA Intramural Research Program Biomedical Research Center 251 Bayview Boulevard, Suite 200 Baltimore, MD, 21224

vii. The provision at FAR Clause 52.212-1 Instructions to Offerors—Commercial Items is applicable to this solicitation. Also, the full text of a solicitation provision may be accessed electronically at these addresses:

https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html

viii. The provision at FAR Clause 52.212-2, Evaluation-Commercial Items applies to this acquisition. The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered.

Selection of an offeror for contract award will be “trade-off”, based on an evaluation of proposals against two factors. The factors are: Technical and Price. Although technical factors are of paramount consideration in the award of the contract, price is also important to the overall contract award decision. The Government intends to make an award to that offeror whose proposal provides the best overall value to the Government.

The evaluation will be based on the demonstrated capabilities of the prospective Contractors in relation to the needs of the project as set forth in the SOLICITATION.

The merits of each proposal will be evaluated carefully. Each proposal must document the feasibility of successful implementation of the requirements of the SOLICITATION.

Offerors must submit information sufficient to evaluate their proposals based on the detailed factors listed below.

The evaluation factors are used when reviewing the proposals.

1. Technical Capability and Functionality

NIDA shall evaluate the offeror’s technical approach for overall capability and functionality in relation to the General Requirement, Salient Characteristics, Quantities and Deliverables.

2. Overall Price

Offerors price quote will be evaluated for reasonableness. For a price to be reasonable, it must represent a price to the government that a prudent person would pay when consideration is given to prices in the market. Normally, price reasonableness is established through adequate price competition, but may also be determined through cost and price analysis techniques.

Offerors may respond with a proposal indicating their ability to provide the technical specifications stated in this solicitation. Responses will be evaluated based on the contractor’s ability to meet the Government’s requirements.

ix. The provision at FAR Clause 52.212-3, Offeror Representations and Certifications Commercial Items, applies to this acquisition.

x. The provision at FAR Clause 52.212-4, Contract Terms and Conditions—Commercial Items, (with NIH Invoice and Payment Provisions) applies to this acquisition.

xi. The provision of FAR Clause 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items, applies to this acquisition. See Attachment 1.

xii. Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. Responses to this solicitation must include clear and convincing evidence of the Offeror’s capability of fulfilling the requirement as it relates to the government requirements stated in this solicitation.

The Contractor shall submit its quote electronically to polina.klimenkova@nih.gov

In addition, the vendor Unique Entity Identifier (UEI) and the certification of business size must be included in the response. All Offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.”

All responses must be received no later than August 28, 2025, 8:00 pm EST. Late responses will not be accepted. All responses must reference solicitation number 75N95025Q00200. For information regarding this solicitation, please contact Polina Klimenkova by email at polina.klimenkova@nih.gov.